AlphaMol - Crunchbase Company Profile & Funding

Q: Where is AlphaMol's headquarters?

AlphaMol is located in Shenzhen, Guangdong, China.

Q: Who invested in AlphaMol?

AlphaMol has 4 investors including New Value Capital And Shanghai Biomedical Industrial Equity Investment Fund.

Q: When was the last funding round for AlphaMol?

AlphaMol closed its last funding round on obfuscated from a Series A round.

Overview

AlphaMol

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About AlphaMol

CB Rank

476256

AlphaMol is a biopharmaceutical company that aims to discover and develop new drug molecules to treat human disorders and diseases.

Founded

obfuscation

Private

Series A

Shenzhen, Guangdong, China

11-50

www.alphamol.com

Biopharma

Biotechnology

Pharmaceutical

Funding Rounds

Series A

OBF

obfuscation

Angel

OBF

obfuscation

Seed

OBF

obfuscation

Details

Legal Name

Shenzhen AlphaMol Technology Co., Ltd.

Also Known As

AlphaMol Science Ltd, 阿尔法

Operating Status

Active

Company Type

For Profit

About the Company

AlphaMol is a biopharmaceutical company that aims to discover and develop new drug molecules to treat human disorders and diseases. It mainly focuses on G protein-coupled receptor (GPCR)-related signaling pathways.

Contact Email

info@alphamol.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AM-001

An oral small molecule drug candidate targeting MRGPRX2 receptor for treating autoimmune diseases such as atopic dermatitis and urticaria.

Less-side effect painkiller compounds

A series of opioid receptor agonists with higher G protein selectivity designed to reduce side effects associated with μ opioid receptor activation.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - AlphaMol	3	obfuscated obfuscation	Shanghai Biomedical Industrial Equity Investment Fund	Series A
obfuscated obfuscation	Series A - AlphaMol	3	obfuscated obfuscation	Shanghai Biomedical Industrial Equity Investment Fund	Series A
obfuscated obfuscation	Series A - AlphaMol	3	obfuscated obfuscation	Shanghai Biomedical Industrial Equity Investment Fund	Series A
obfuscated obfuscation	Series A - AlphaMol	3	obfuscated obfuscation	Shanghai Biomedical Industrial Equity Investment Fund	Series A
obfuscated obfuscation	Series A - AlphaMol	3	obfuscated obfuscation	Shanghai Biomedical Industrial Equity Investment Fund	Series A

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - AlphaMol	3	obfuscated obfuscation	Shanghai Biomedical Industrial Equity Investment Fund	Series A
obfuscated obfuscation	Series A - AlphaMol	3	obfuscated obfuscation	Shanghai Biomedical Industrial Equity Investment Fund	Series A
obfuscated obfuscation	Series A - AlphaMol	3	obfuscated obfuscation	Shanghai Biomedical Industrial Equity Investment Fund	Series A
obfuscated obfuscation	Series A - AlphaMol	3	obfuscated obfuscation	Shanghai Biomedical Industrial Equity Investment Fund	Series A
obfuscated obfuscation	Series A - AlphaMol	3	obfuscated obfuscation	Shanghai Biomedical Industrial Equity Investment Fund	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
New Value Capital	—	Series A - AlphaMol	—
New Value Capital	—	Series A - AlphaMol	—
New Value Capital	—	Series A - AlphaMol	—
New Value Capital	—	Series A - AlphaMol	—
New Value Capital	—	Series A - AlphaMol	—